STERIS plc (STE) Operating Margin
- Operating margin · 12 months: Value 18.91%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 18.91% | Operating income / revenue. Period ending 2026-06-30. $1.14B ÷ $6.04B × 100 ≈ 18.91% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.14B USD | Operating Income (Loss) |
| Revenue | 6.04B USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 115.10M USD | Research and Development Expense |
| Selling, general and administration | 1.42B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.14B | $6.04B | (m) | $115.10M | $1.42B | 18.91% |
| 2026-03-31 | $1.10B | $5.94B | $3.31B | $112.90M | $1.41B | 18.56% |
| 2025-12-31 | $1.00B | $5.83B | (m) | $111.75M | $1.39B | 17.18% |
| 2025-09-30 | $973.24M | $5.70B | (m) | $109.65M | $1.37B | 17.07% |
| 2025-06-30 | $927.14M | $5.57B | (m) | $108.45M | $1.35B | 16.64% |
| 2025-03-31 | $866.64M | $5.46B | $3.06B | $107.65M | $1.33B | 15.87% |
| 2024-12-31 | $870.82M | $5.40B | (m) | $107.42M | $1.31B | 16.13% |
| 2024-09-30 | $852.00M | $5.33B | (m) | $105.32M | $1.28B | 16.00% |
| 2024-06-30 | $823.89M | $5.23B | (m) | $104.56M | $1.28B | 15.74% |
| 2024-03-31 | $836.12M | $5.14B | $2.92B | $103.68M | $1.25B | 16.27% |
| 2023-12-31 | $816.30M | $5.41B | (m) | $104.85M | $1.44B | 15.10% |
| 2023-09-30 | $790.94M | $5.23B | (m) | $104.45M | $1.38B | 15.13% |
| 2023-06-30 | $298.67M | $5.09B | (m) | $102.33M | $1.32B | 5.87% |
| 2023-03-31 | $268.19M | $4.96B | $2.80B | $101.58M | $1.30B | 5.41% |
| 2022-12-31 | $134.64M | $4.78B | (m) | $101.29M | $1.42B | 2.81% |
| 2022-09-30 | $146.77M | $4.78B | (m) | $100.60M | $1.42B | 3.07% |
| 2022-06-30 | $569.69M | $4.77B | $2.67B | $94.50M | $1.44B | 11.94% |
| 2022-03-31 | $425.62M | $4.59B | $2.57B | $87.94M | $1.50B | 9.28% |
| 2021-12-31 | $478.02M | $4.25B | (m) | $79.36M | $1.27B | 11.25% |
| 2021-09-30 | $422.12M | $3.85B | (m) | $70.98M | $1.14B | 10.97% |
| 2021-06-30 | $446.88M | $3.41B | (m) | $68.29M | $969.90M | 13.12% |
| 2021-03-31 | $548.37M | $3.11B | $1.76B | $66.33M | $731.32M | 17.65% |
| 2020-12-31 | $560.06M | $3.06B | (m) | $66.04M | $699.31M | 18.32% |
| 2020-09-30 | $555.42M | $3.02B | (m) | $66.09M | $689.87M | 18.38% |
| 2020-06-30 | $540.89M | $3.00B | (m) | $66.19M | $693.12M | 18.01% |
| 2020-03-31 | $536.97M | $3.03B | (m) | $65.55M | $716.73M | 17.72% |
| 2019-12-31 | $520.09M | $2.98B | (m) | $64.20M | $700.79M | 17.48% |
| 2019-09-30 | $447.28M | $2.90B | (m) | $62.88M | $703.96M | 15.43% |
| 2019-06-30 | $427.13M | $2.84B | (m) | $62.40M | $690.31M | 15.04% |
| 2019-03-31 | $411.46M | $2.78B | (m) | $63.04M | $669.94M | 14.79% |
| 2018-12-31 | (m) | $2.73B | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $2.70B | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $2.65B | (m) | (m) | (m) | (m) |
| 2018-03-31 | $399.88M | $2.62B | (m) | $60.78M | $631.98M | 15.26% |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $226.21M | $2.61B | (m) | $59.40M | $682.04M | 8.66% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |